Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1996 1
1997 1
1998 1
2000 1
2001 1
2002 4
2003 7
2004 3
2005 12
2006 8
2007 8
2008 7
2009 16
2010 6
2011 8
2012 9
2013 8
2014 13
2015 10
2016 13
2017 10
2018 5
2019 13
2020 7
2021 11
2022 13
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
Krishnan SM, Ling YH, Huuskes BM, Ferens DM, Saini N, Chan CT, Diep H, Kett MM, Samuel CS, Kemp-Harper BK, Robertson AAB, Cooper MA, Peter K, Latz E, Mansell AS, Sobey CG, Drummond GR, Vinh A. Krishnan SM, et al. Among authors: samuel cs. Cardiovasc Res. 2019 Mar 15;115(4):776-787. doi: 10.1093/cvr/cvy252. Cardiovasc Res. 2019. PMID: 30357309 Free PMC article.
Preclinical rodent models of cardiac fibrosis.
Wang Y, Wang M, Samuel CS, Widdop RE. Wang Y, et al. Among authors: samuel cs. Br J Pharmacol. 2022 Mar;179(5):882-899. doi: 10.1111/bph.15450. Epub 2021 May 10. Br J Pharmacol. 2022. PMID: 33973236 Free article. Review.
Anti-fibrotic actions of relaxin.
Samuel CS, Royce SG, Hewitson TD, Denton KM, Cooney TE, Bennett RG. Samuel CS, et al. Br J Pharmacol. 2017 May;174(10):962-976. doi: 10.1111/bph.13529. Epub 2016 Jul 7. Br J Pharmacol. 2017. PMID: 27250825 Free PMC article. Review.
Anti-fibrotic Potential of AT2 Receptor Agonists.
Wang Y, Del Borgo M, Lee HW, Baraldi D, Hirmiz B, Gaspari TA, Denton KM, Aguilar MI, Samuel CS, Widdop RE. Wang Y, et al. Among authors: samuel cs. Front Pharmacol. 2017 Aug 31;8:564. doi: 10.3389/fphar.2017.00564. eCollection 2017. Front Pharmacol. 2017. PMID: 28912715 Free PMC article. Review.
Understanding relaxin signalling at the cellular level.
Valkovic AL, Bathgate RA, Samuel CS, Kocan M. Valkovic AL, et al. Among authors: samuel cs. Mol Cell Endocrinol. 2019 May 1;487:24-33. doi: 10.1016/j.mce.2018.12.017. Epub 2018 Dec 25. Mol Cell Endocrinol. 2019. PMID: 30592984 Review.
Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis.
Pinar AA, Scott TE, Huuskes BM, Tapia Cáceres FE, Kemp-Harper BK, Samuel CS. Pinar AA, et al. Among authors: samuel cs. Pharmacol Ther. 2020 May;209:107511. doi: 10.1016/j.pharmthera.2020.107511. Epub 2020 Feb 22. Pharmacol Ther. 2020. PMID: 32097669 Review.
182 results